| Line item | 2026-01-31 FY | 2025-02-01 FY | 2024-02-03 FY | 2023-01-28 FY | 2022-01-29 FY |
|---|---|---|---|---|---|
| Revenue | $6.55B | $6.23B | $6.18B | $6.34B | $6.79B |
| Cost of Revenue | $4.17B | $3.95B | $3.94B | $4.09B | $4.03B |
| Gross Profit | $2.38B | $2.28B | $2.24B | $2.26B | $2.76B |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $2.11B | $1.97B | $2.00B | $1.78B | $1.89B |
| Operating Income | $271.00M | $310.00M | $246.00M | $478.00M | $870.00M |
| Interest Expense | – | – | $99.00M | $60.00M | $27.00M |
| Tax Expense | $19.00M | $52.00M | $31.00M | $79.00M | $197.00M |
| Net Income | $161.00M | $165.00M | $109.00M | $348.00M | $646.00M |
| EPS (basic) | 2.0000 | 2.1100 | 1.4100 | 4.2400 | 7.3400 |
| EPS (diluted) | 1.9300 | 2.0500 | 1.3900 | 4.1400 | 7.1800 |
| Shares (diluted) | $83.00M | $81.00M | $79.00M | $84.00M | $90.00M |